Delivery Order 36C26322D0009-36C26323N0133
- Not listed
- The Department of Veterans Affairs Veterans Integrated Service Network 23 awarded a delivery order valued at $19,500 to Diasorin Molecular, LLC for COVID-19 tests and analyzers. The award, issued on October 1, 2023, with an ultimate completion date of September 30, 2024, carries firm fixed pricing and represents a non-competitive procurement with no set-aside designation. This delivery order is issued under a larger $10 million Indefinite Delivery Vehicle established between VA VISN 23 and...
- Diasorin Molecular LLC has been awarded a firm-fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 for $220,040.76 to provide Diasorin reagents and supplies for COVID-19 testing through December 2022. The award was issued on December 21, 2021 without a set-aside designation. Diasorin Molecular LLC will deliver the requested reagents and supplies to support coronavirus disease testing at VA medical facilities in...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $218,853.71 firm fixed price delivery order to Diasorin Molecular LLC of Cypress, California. The delivery order is for COVID tests and analyzers to support VHA's pandemic response efforts. Performance will take place in Cypress and conclude by September 30, 2022. No set-aside designation was applied to this procurement for COVID-19 diagnostic products. Diasorin Molecular will...
- This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Diasorin Molecular LLC, a foreign-owned for-profit manufacturer of medical diagnostic products and testing equipment. The contract, valued at $73,226.83, is for Diasorin's Simplexa molecular diagnostic tests and analyzers to support COVID-19 testing and surveillance at VA medical facilities in California and Minnesota. The contract is not set aside and was issued under a...
- This federal contract award to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment, was made by the U.S. Department of Veterans Affairs (VA) through Veterans Integrated Service Network (VISN) 23. The $169,000.00 Firm Fixed Price delivery order contract, which does not have a set-aside designation, is for the provision of COVID-19 tests and analyzers to support the VA's pandemic response and ongoing infectious disease testing...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $397,062.09 firm fixed price delivery order to Diasorin Molecular LLC of Cypress, California. The delivery order is for COVID tests and analyzers to support VHA's pandemic response efforts. Performance is to be completed by September 30, 2022 at locations within the agency's Southern California region. No set-aside provisions were applied to this competitive award, which will...
- This federal contract award to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products, is for the delivery of COVID-19 tests and analyzers to the Veterans Integrated Service Network (VISN) 23 of the Department of Veterans Affairs (VA). The contract, valued at $498,757.12, is a Firm Fixed Price Delivery Order with a period of performance through September 30, 2023. This award is part of a larger $10 million single-award Indefinite Delivery Vehicle (IDV)...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $0.00 firm fixed price delivery order to Diasorin Molecular LLC of Cypress, California. The order is for FY23 COVID analyzer and testing kits to support the agency's pandemic response efforts. Performance will take place in Cypress and conclude by September 30, 2023. No set-aside provisions were applied to this award made under an unspecified multiple award contract vehicle. The...
- The U.S. Department of Veterans Affairs (VA) awarded a Delivery Order contract worth $28,316.49 to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment. The contract is to provide COVID-19 tests and analyzers to support the VA's pandemic response efforts across its Veterans Integrated Service Network (VISN) 23. Diasorin Molecular has previously been awarded several Indefinite Delivery Vehicle (IDV) contracts by the VA to supply...
- Diasorin Molecular LLC was awarded a single award, one-year indefinite delivery/indefinite quantity contract with a potential value of $311,278.87 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23. The firm fixed price delivery order is for real-time polymerase chain reaction instrumentation to support COVID-19 and influenza testing through September 20, 2021. No set-aside provisions were applied to this award made under an existing...
- 36C26322D0009Indefinite Delivery Contract
- 36C26322D0009-36C26323N0133Delivery Order
Diasorin Molecular LLC has been awarded a $9,467.20 firm-fixed-price delivery order against the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 single-award indefinite delivery contract to provide COVID-19 diagnostic tests and analyzers in Cypress, California. The delivery order has a completion date of September 30, 2026 and was awarded on October 1, 2022. The contract vehicle was awarded without a set-aside designation to support the VA's efforts in responding to the COVID-19 pandemic. Diasorin Molecular LLC is a foreign-owned, for-profit manufacturer that has previously delivered COVID-19 and influenza diagnostics as well as testing reagents for herpes and cytomegalovirus to various VA medical centers through task orders issued against the company's contracts with VA VISNs 1 and 23.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($136k) | 2/16/24 | |
| Not listed | Not listed | $145.6k | 10/1/22 |